Business Information
The group's principal activities are to develop, manufacture and market diagnostic products. It is used for the serologic diagnosis of certain vascular diseases and autoimmune disorders using proprietary technology. The group's products include autoimmune disease products. The group markets its products to hospitals and free-standing laboratories worldwide through a network of sales representatives, distributors and private label agreements. The group sold its products through established diagnostic companies in Argentina, Australia, Austria, Belgium, Brazil, and Canada. It also sells in Chile, Denmark, Egypt, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Kuwait, Lebanon, Malaysia, Mexico, the Netherlands, Norway, Paraguay, Peru, Portugal, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, the United Kingdom, and Uruguay. The group's trademark is Reaads.
|
|
Name |
Title
|
Email
|
| Luis Lopez | Chmn. | N/A | | Douglass Simpson | CEO, Pres. | N/A | | Paul Bates | MD | N/A | | William Critchfield | Sr. VP, CFO | N/A | | Ann Steinbarger | Sr. VP - Operations | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 6,636 | (1,586) | | 2005 | 5,565 | (582) | | 2004 | 5,271 | (125)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
